These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 33158544)
21. R848, a Toll-like receptors 7 and 8 agonist, a potential therapy for allergic rhinitis patients. Boghdadi G; Hammad N; Amer A; Sammour S; Sorour S Inflamm Allergy Drug Targets; 2014; 13(2):144-9. PubMed ID: 24773332 [TBL] [Abstract][Full Text] [Related]
22. The Toll-like receptor 7/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-activating factor biosynthesis. Hattermann K; Picard S; Borgeat M; Leclerc P; Pouliot M; Borgeat P FASEB J; 2007 May; 21(7):1575-85. PubMed ID: 17264163 [TBL] [Abstract][Full Text] [Related]
23. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. Nagase H; Okugawa S; Ota Y; Yamaguchi M; Tomizawa H; Matsushima K; Ohta K; Yamamoto K; Hirai K J Immunol; 2003 Oct; 171(8):3977-82. PubMed ID: 14530316 [TBL] [Abstract][Full Text] [Related]
24. Regulation of mRNA levels of TNF-alpha and the alpha chain of the high-affinity receptor for IgE in mast cells by IFN-gamma and alpha/beta. Enciso JA; Bissonnette EY; Befus AD Int Arch Allergy Immunol; 1996 Jun; 110(2):114-23. PubMed ID: 8645988 [TBL] [Abstract][Full Text] [Related]
25. Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes. Serrano R; Wesch D; Kabelitz D Cells; 2020 Mar; 9(3):. PubMed ID: 32183240 [TBL] [Abstract][Full Text] [Related]
26. Suppressive effect of β,β-dimethylacryloyl alkannin on activated dendritic cells in psoriasis by the TLR7/8 pathway. Wang Y; Zhao J; Di T; Wang M; Ruan Z; Zhang L; Xie X; Meng Y; Lin Y; Liu X; Wang N; Li P Int Immunopharmacol; 2016 Nov; 40():410-418. PubMed ID: 27697724 [TBL] [Abstract][Full Text] [Related]
29. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362 [TBL] [Abstract][Full Text] [Related]
30. Mannan activates tissue native and IgE-sensitized mast cells to proinflammatory response and chemotaxis in TLR4-dependent manner. Żelechowska P; Brzezińska-Błaszczyk E; Różalska S; Agier J; Kozłowska E J Leukoc Biol; 2021 May; 109(5):931-942. PubMed ID: 33047839 [TBL] [Abstract][Full Text] [Related]
31. TLR7 Modulated T Cell Response in the Mesenteric Lymph Node of Qu J; Yu X; Jin C; Feng Y; Xie S; Xie H; Yang Q; Qi Y; Qiu H; Chen H; Mu J; Zhou Y; Huang J J Immunol Res; 2019; 2019():2691808. PubMed ID: 31930147 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice. Rostamian M; Niknam HM Mol Immunol; 2017 Nov; 91():202-208. PubMed ID: 28963929 [TBL] [Abstract][Full Text] [Related]
33. Molecular cloning and functional analysis of peafowl (Pavo cristatus) Toll-like receptor 7. Song H; Zhang M; Gao W; Wu L; Li G Poult Sci; 2018 Jan; 97(1):294-302. PubMed ID: 29053867 [TBL] [Abstract][Full Text] [Related]
34. Immune response in the duck intestine following infection with low-pathogenic avian influenza viruses or stimulation with a Toll-like receptor 7 agonist administered orally. Volmer C; Soubies SM; Grenier B; Guérin JL; Volmer R J Gen Virol; 2011 Mar; 92(Pt 3):534-43. PubMed ID: 21123544 [TBL] [Abstract][Full Text] [Related]
36. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells. Lombardi V; Van Overtvelt L; Horiot S; Moingeon P J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114 [TBL] [Abstract][Full Text] [Related]
37. Systemic cancer therapy with a small molecule agonist of toll-like receptor 7 can be improved by circumventing TLR tolerance. Bourquin C; Hotz C; Noerenberg D; Voelkl A; Heidegger S; Roetzer LC; Storch B; Sandholzer N; Wurzenberger C; Anz D; Endres S Cancer Res; 2011 Aug; 71(15):5123-33. PubMed ID: 21697281 [TBL] [Abstract][Full Text] [Related]
38. Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator. Lu R; Groer C; Kleindl PA; Moulder KR; Huang A; Hunt JR; Cai S; Aires DJ; Berkland C; Forrest ML J Control Release; 2019 Jul; 306():165-176. PubMed ID: 31173789 [TBL] [Abstract][Full Text] [Related]
39. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism. Niu C; Li L; Daffis S; Lucifora J; Bonnin M; Maadadi S; Salas E; Chu R; Ramos H; Livingston CM; Beran RK; Garg AV; Balsitis S; Durantel D; Zoulim F; Delaney WE; Fletcher SP J Hepatol; 2018 May; 68(5):922-931. PubMed ID: 29247725 [TBL] [Abstract][Full Text] [Related]
40. TLR7 is a key regulator of innate immunity against Japanese encephalitis virus infection. Nazmi A; Mukherjee S; Kundu K; Dutta K; Mahadevan A; Shankar SK; Basu A Neurobiol Dis; 2014 Sep; 69():235-47. PubMed ID: 24909816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]